MiniSOX9, a dominant-negative variant in colon cancer cells R Abdel-Samad, H Zalzali, C Rammah, J Giraud, C Naudin, S Dupasquier, ... Oncogene 30 (22), 2493-2503, 2011 | 47 | 2011 |
Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma H El Hajj, B Khalil, B Ghandour, R Nasr, S Shahine, A Ghantous, ... Blood, The Journal of the American Society of Hematology 124 (13), 2072-2080, 2014 | 37 | 2014 |
Mechanism of action of the atypical retinoid ST1926 in colorectal cancer: DNA damage and DNA polymerase α R Abdel-Samad, P Aouad, H Gali-Muhtasib, Z Sweidan, R Hmadi, ... American journal of cancer research 8 (1), 39, 2018 | 36 | 2018 |
Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models P Aouad, M Saikali, R Abdel-Samad, S Fostok, L El-Houjeiri, C Pisano, ... Anti-Cancer Drugs 28 (7), 757-770, 2017 | 30 | 2017 |
Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells F Ballout, A Monzer, M Fatfat, H El Ouweini, MA Jaffa, R Abdel-Samad, ... Oncotarget 11 (31), 2959, 2020 | 28 | 2020 |
A new mechanism of SOX9 action to regulate PKCα expression in the intestine epithelium S Dupasquier, R Abdel-Samad, RI Glazer, P Bastide, P Jay, D Joubert, ... Journal of cell science 122 (13), 2191-2196, 2009 | 24 | 2009 |
The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem‐like cells HF Bahmad, H Samman, A Monzer, O Hadadeh, K Cheaito, ... Molecular carcinogenesis 58 (7), 1208-1220, 2019 | 19 | 2019 |
Antitumor effect of the atypical retinoid ST1926 in acute myeloid leukemia and nanoparticle formulation prolongs lifespan and reduces tumor burden of xenograft mice L El-Houjeiri, W Saad, B Hayar, P Aouad, N Tawil, R Abdel-Samad, ... Molecular Cancer Therapeutics 16 (10), 2047-2057, 2017 | 13 | 2017 |
Natural and synthetic retinoids in preclinical colorectal cancer models R Abdel-Samad, P Aouad, N Darwiche Anti-Cancer Drugs 30 (7), 655-669, 2019 | 9 | 2019 |
Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models L Karam, B Houshaymi, R Abdel-Samad, M Jaafar, I Halloum, C Pisano, ... Oncology Reports 39 (2), 721-730, 2018 | 9 | 2018 |
Targeting colorectal cancer stem cells with the anticancer molecule thymoquinone FR Ballout, M Fatfat, R Abdel-Samad, N Darwiche, R Schneider-Stock, ... Cancer Research 78 (13_Supplement), 170-170, 2018 | 1 | 2018 |
Combination treatments with retinoic acid and the synthetic retinoid ST1926 in 2D and 3D breast cancer models overcome retinoic acid resistance and eradicate breast cancer stem … P Aouad, M Saikali, R Abdel-Samad, L El–Houjeiri, C Pisano, R Talhouk, ... Cancer Research 76 (14_Supplement), 1189-1189, 2016 | 1 | 2016 |
Encapsulation of the atypical retinoid ST1926 in nanoparticles prolongs the survival of acute myeloid leukemia xenografted mice at multiple folds lower concentrations than the … L El-Houjeiri, W Saad, B Hayar, P Aouad, N Tawil, R Abdel-Samad, ... Cancer Research 77 (13_Supplement), 5140-5140, 2017 | | 2017 |
846: Antitumor activity of the synthetic retinoid ST1926 in colorectal cancer cells: involvement of DNA damage N Darwiche, R Abdel-Samad, R Hmadi, M El-Sabban, H Muhtasib, ... European Journal of Cancer, S206, 2014 | | 2014 |
SOX9 et MiniSOX9 dans la tumorigenèse intestinale R Abdel-Samad Montpellier 2, 2010 | | 2010 |
SOX9 and its new splice variant MiniSOX9 in colon tumor R Abdel-Samad, H Zalzali, J Giraud, C Naudin, S Dupasquier, F Poulat, ... FEBS JOURNAL 277, 273-273, 2010 | | 2010 |
656 MiniSOX9, a dominant-negative isoform of the transcription factor SOX9 in colon tumour cells P Raynaud, R Abdel-Samad, H Zalzali, J Giraud, C Naudin, S Dupasquier, ... ejc supplements 5 (8), 166, 2010 | | 2010 |
A new SOX9-dependent mechanism to regulate PKCa expression in the intestine epithelium S Dupasquier, R Abdel-Samad, P Bastide, P Jay, D Joubert, P Blache, ... BULLETIN DU CANCER 95, S28-S28, 2008 | | 2008 |